<u id="zkwwc"><dd id="zkwwc"></dd></u>

<sub id="zkwwc"></sub>
<dd id="zkwwc"></dd><nav id="zkwwc"></nav>

        Analyst Coverage

        To our knowledge the following list presents the analysts publishing material commenting on Abcam. We provide this list for your convenience only and do not endorse or express any opinion on the reports these analysts publish.

        Company Analyst
        Berenberg Charles Weston
        Investec Andrew Whitney
        JP Morgan Cazenove David Adlington
        Numis Securities Stefan Hamill
        Panmure Gordon & Co Julie Simmonds
        Peel Hunt Amy Walker
        RBC Securities Nick Keher
        Stifel James Mainwaring

        About Abcam

        Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

        Read more +

        Abcam Products

        As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

        Read more +

        Investor Information

        Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

        Read more +

        Abcam News

        We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

        Read more +